The landscape of dementia prognosis has evolved radically with the arrival of subtle biomarkers, which includes amyloid PET scans, tau imaging, and blood-centered tests that will detect Alzheimer's pathology decades prior to indicators arise. While these technological developments depict extraordinary progress in knowing neurodegenerative condition